产品封面图

小鼠体内用IL-4抗体,体内IL-4中和,体外IL-4中和,

体内IL-4受体刺激
收藏
  • ¥5600
  • bioXCELL
  • 美国
  • BE0045-5mg
  • 2026年01月14日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 询价记录
    • 文献和实验
    • 技术资料
    • 克隆性

      多克隆

    • 抗体英文名

      InVivoMAb anti-mouse IL-4

    • 抗体名

      小鼠体内用IL-4抗体,体内IL-4中和,体外IL-4中和,体内IL-4受体刺激

    • 规格

      5mg

    小鼠体内用IL-4抗体,体内IL-4中和,体外IL-4中和,体内IL-4受体刺激
    Bio X Cell抗体优势:
    ✔ 通过大规模的组织培养生产抗体,亲和层析法纯化抗体,
    ✔ 所有抗体均具有高纯度(>95%)、低内毒素(<2EU/mg),无防腐剂和稳定剂的特性,适用于体内临床前研究
    ✔ 所有抗体可提供100mg甚至50g的大包装,性价比非常高
    Bio X Cell抗体应用
    产品细节图片1
    热销抗体
    抗原 应用 克隆号 InVivoMab
    目录号
    InVivoPlus
    目录号
    PD-1 体内PD-1/PD-L1信号封闭 RMP1-14 BE0146 BP0146
    体内PD-1/PD-L1信号封闭,体外PD-1中和,IHC(冰冻),IF,WB,FC 29F.1A12 BE0273 BP0273
    体内PD-1/PD-L1信号封闭,体外PD-1中和,WB J43 BE0033-2 BP0033-2
    InVivo rat IgG2a isotype control, PD-1同型对照,排除Fc段与抗原的非特异性结合 2A3 BE0089 BP0089
    PD-L1(B7-H1) 体内PD-L1信号封闭,IF,IHC(冰冻),FC,WB 10F.9G2 BE0101 BP0101
    InVivo rat IgG2b isotype control, PD-L1同型对照,排除Fc段与抗原的非特异性结合 LTF-2 BE0090 BP0090
    CTLA-4 体内 CTLA-4 中和,WB 9D9 BE0164 BP0164
    体内和体外中和CTLA-4,WB 9H10 BE0131 BP0131
    体内和体外中和CTLA-4,FC,WB UC10-
    4F10-11
    BE0032 BP0032
    NK1.1 体内NK细胞去除,FC PK136 BE0036 BP0036
    CD3ε 体内T细胞去除,体外T细胞刺激/激活,IF,FC,WB, 145-2C11 BE0001-1 BP0001-1
    CD4 体内CD4+T细胞去除,FC,WB GK1.5 BE0003-1 BP0003-1
    CD8α 体内CD8+T细胞去除,IF,FC,WB 53-6.7 BE0004-1 BP0004-1
    CD25 (IL-2Rα) 体内调节T细胞去除,FC PC-61.5.3 BE0012 BP0012
    CD28 体内CD8封闭,体外T细胞刺激/激活 37.51 BE0015-1 /
    体外T细胞刺激/激活 PV-1 BE0015-5 /
    CSF1R (CD115) 体内巨噬细胞去除,体外CSF-R1中和,体内单核细胞去除, FC,WB AFS98 BE0213 BP0213
    IL-4 体内IL-4中和,体外IL-4中和,体内IL-4受体刺激(as a complex with IL-4)
    FC,WB
    11B11 BE0045 BP0045
    IFNγ (interferon
    gamma)
    体内IFNγ中和,体外IFNγ中和,ELISPOT,FC,WB XMG1.2 BE0055 BP0055
    Ly6G 体内中性粒细胞耗竭,体内MDSC耗尽, IF,IHC(石蜡或冰冻),FC 1A8 BE0075-1 BP0075-1
    Ly6G/Ly6C (Gr-1) 体内Gr-1+骨髓细胞去除,IHC(石蜡或冰冻),FC RB6-8C5 BE0075 BP0075
    IFNAR-1 体内IFNAR-1阻断,体外IFNAR-1阻断,WB MAR1-5A3 BE0241 BP0241
    InVivoMab VS InVivoPlus
    - InVivoMab InVivoPlus
    纯度 >95% >95%
    蛋白完整性 √(SDS-PAGE) √(SDS-PAGE)
    内毒素浓度 2EU/mg <1EU/mg
    有效性验证(WB/FC/ELISA)
    蛋白聚集物<5%
    小鼠病原体测试
    无叠氮化物和载体蛋白
    大批量生产
    适用体内研究
    目录号 BE开头 BP开头
    InVivoPlusTM 系列抗体非常适用于高灵敏性实验以及用活细胞或整个动物进行各种功能测定的体内研究,可加快您的研究进展。

    热销同型对照和InVivoPure抗体稀释Buffer
    产品类型 品名 用途 InVivoMab
    目录号
    InVivoPlus
    目录号
    部分热卖同型
    对照
    InVivoMab rat IgG2a isotype control 排除一抗的Fc段与
    抗原的非特异性结合,
    使实验结果更加严谨,
    有助于您发表高分论文
    BE0089 BP0089
    InVivoMab rat IgG2b isotype control BE0090 BP0090
    InVivoMab mouse IgG1 isotype control BE0083 BP0083
    InVivoMAb human IgG1 isotype control BE0297 BP0297
    InVivoPlus rat IgG2a isotype control BE0089 BP0089
    InVivoMab mouse IgG2a isotype control BE0085 BP0085
    InVivoMabrat IgG1 isotype control BE0088 BP0088
    InVivoPlus mouse IgG1 isotype control BE0083 BP0083
    InVivoMAb polyclonal Armenian hamster IgG BE0091 BP0091
    抗体稀释Buffer InVivoPure pH 7.0 Dilution Buffer 官方指定抗体稀释
    buffer,确保抗体使用
    性能,加快您的实验进展
    IP0070 /
    InVivoPure pH 6.5 Dilution Buffer IP0065 /
    ✔ 为了加快您实验进度,确保实验结果的准确性,建议您搭配使用Bio X Cell一抗对应的同型对照(排除一抗的非特异性结合)和InVivoPure抗体稀释缓冲液。

    About InVivoMAb anti-mouse IL-4

    The 11B11 monoclonal antibody reacts with mouse IL-4 (interleukin-4) a multifunctional 14 kDa cytokine. IL-4 is expressed primarily by activated Th2 cells and NK cells, and at lower levels by mast cells, and basophils. IL-4 signals through the IL-4Rα. Upon receptor binding IL-4 stimulates activated B and T lymphocyte proliferation, and the differentiation of B cells into plasma cells. It also induces B cell class switching to IgE, and up-regulates MHC class II production while decreasing the production of Th1 cells, macrophages, IFNγ, and dendritic cell IL-12. Like other Th2 associated cytokines, IL-4 is involved in the airway inflammation observed in the lungs of patients with allergic asthma. The 11B11 monoclonal antibody has been shown to neutralize the bioactivity of natural or recombinant IL-4.

    InVivoMAb anti-mouse IL-4 Specifications

    Isotype Rat IgG1, κ
    Recommended Isotype Control(s) InVivoMAb rat IgG1 isotype control, anti-horseradish peroxidase(BE0088)
    Recommended InVivoPure Dilution Buffer InVivoPure pH 7.0 Dilution Buffer(IP0070)
    Immunogen Partially purified native mouse IL-4
    Reported Applications
    • in vivo IL-4 neutralization
    • in vitro IL-4 neutralization
    • in vivo IL-4 receptor stimulation (as a complex with IL-4)
    • Flow cytometry
    • Western blot
    Endotoxin
    • <2EU/mg (<0.002EU/μg)
    • Determined by LAL gel clotting assay
    Purity
    • >95%
    • Determined by SDS-PAGE
    Formulation
    • PBS, pH 7.0
    • Contains no stabilizers or preservatives
    Sterility 0.2 μM filtered
    Production Purified from tissue culture supernatant in an animal free facility
    Purification Protein G
    Storage The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
    RRID AB_1107707
    Molecular Weight 150 kDa

    Application References

    InVivoMAb anti-mouse IL-4 (Clone: 11B11)

    Gaya, M., et al. (2018). "Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells." Cell 172(3): 517-533 e520. PubMed B cells constitute an essential line of defense from pathogenic infections through the generation of class-switched antibody-secreting cells (ASCs) in germinal centers. Although this process is known to be regulated by follicular helper T (TfH) cells, the mechanism by which B cells initially seed germinal center reactions remains elusive. We found that NKT cells, a population of innate-like T lymphocytes, are critical for the induction of B cell immunity upon viral infection. The positioning of NKT cells at the interfollicular areas of lymph nodes facilitates both their direct priming by resident macrophages and the localized delivery of innate signals to antigen-experienced B cells. Indeed, NKT cells secrete an early wave of IL-4 and constitute up to 70% of the total IL-4-producing cells during the initial stages of infection. Importantly, the requirement of this innate immunity arm appears to be evolutionarily conserved because early NKT and IL-4 gene signatures also positively correlate with the levels of neutralizing antibodies in Zika-virus-infected macaques. In conclusion, our data support a model wherein a pre-TfH wave of IL-4 secreted by interfollicular NKT cells triggers the seeding of germinal center cells and serves as an innate link between viral infection and B cell immunity. Clever, D., et al. (2016). "Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche." Cell 166(5): 1117-1131 e1114. PubMed Cancer cells must evade immune responses at distant sites to establish metastases. The lung is a frequent site for metastasis. We hypothesized that lung-specific immunoregulatory mechanisms create an immunologically permissive environment for tumor colonization. We found that T-cell-intrinsic expression of the oxygen-sensing prolyl-hydroxylase (PHD) proteins is required to maintain local tolerance against innocuous antigens in the lung but powerfully licenses colonization by circulating tumor cells. PHD proteins limit pulmonary type helper (Th)-1 responses, promote CD4(+)-regulatory T (Treg) cell induction, and restrain CD8(+) T cell effector function. Tumor colonization is accompanied by PHD-protein-dependent induction of pulmonary Treg cells and suppression of IFN-gamma-dependent tumor clearance. T-cell-intrinsic deletion or pharmacological inhibition of PHD proteins limits tumor colonization of the lung and improves the efficacy of adoptive cell transfer immunotherapy. Collectively, PHD proteins function in T cells to coordinate distinct immunoregulatory programs within the lung that are permissive to cancer metastasis. Choi, Y. S., et al. (2015). "LEF-1 and TCF-1 orchestrate TFH differentiation by regulating differentiation circuits upstream of the transcriptional repressor Bcl6." Nat Immunol 16(9): 980-990. PubMed Follicular helper T cells (TFH cells) are specialized effector CD4(+) T cells that help B cells develop germinal centers (GCs) and memory. However, the transcription factors that regulate the differentiation of TFH cells remain incompletely understood. Here we report that selective loss of Lef1 or Tcf7 (which encode the transcription factor LEF-1 or TCF-1, respectively) resulted in TFH cell defects, while deletion of both Lef1 and Tcf7 severely impaired the differentiation of TFH cells and the formation of GCs. Forced expression of LEF-1 enhanced TFH differentiation. LEF-1 and TCF-1 coordinated such differentiation by two general mechanisms. First, they established the responsiveness of naive CD4(+) T cells to TFH cell signals. Second, they promoted early TFH differentiation via the multipronged approach of sustaining expression of the cytokine receptors IL-6Ralpha and gp130, enhancing expression of the costimulatory receptor ICOS and promoting expression of the transcriptional repressor Bcl6. Gu, A. D., et al. (2015). "A critical role for transcription factor Smad4 in T cell function that is independent of transforming growth factor beta receptor signaling." Immunity 42(1): 68-79. PubMed

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标文献和实验
    相关实验
    • 新冠病毒及变异株疫苗新突破:环状 RNA 疫苗

      病毒刺突蛋白(Spike)受体结构域(RBD)的环状 RNA 疫苗。 实验证明,该疫苗可以在小鼠和恒河猴体内诱导产生高水平的新冠病毒中和抗体以及特异性 T 细胞免疫反应,并可以有效降低新冠病毒感染的恒河猴肺部的病毒载量,显著缓解新冠病毒感染引起的肺炎症状。 CircRNA 疫苗接种在小鼠和恒河猴体内提供了显著性保护 二、环状 RNA 疫苗的优势 一系列的对比评估表明,与 mRNA 疫苗相比,circRNA 疫苗具有以下特点或优势: 1)circRNA 具有更高的稳定性,可以在体内

    • AAV 在肝脏研究中的应用策略

      与性别会影响到感染效率,一般会选择雄性小鼠做实验。 ② AAV2/3B 载体对人肝脏的感染效率明显,对 NHPS 也有效,但不能有效地转导 MOUSE 肝脏。   AAV 在肝脏应用中的局限及解决方式 肝细胞的自我更新会稀释体内 AAV 导致降低转导效率 重新注射新的血清型 使用药物阻断免疫应答重新注射同种血清型 AAV 基因整合到小鼠基因组上   体内预存的抗 AAV 中和抗体降低转导效率 实验前做中和抗体预筛,选择无中和抗体小鼠 使用不同的血清型进行小鼠实验 预先处理小鼠来抑制其免疫应答再进行

    • Cancer Cell:曹雪涛院士团队揭示肿瘤相关巨噬细胞中葡萄糖代谢的增加可促进癌症转移

      缺失 OGT 时不能进一步降低肿瘤细胞的侵袭;而在条件培养液中补充重组 CTSB 则可以挽救巨噬细胞中 OGT 缺乏导致的肿瘤细胞侵袭率的降低。 图片来源:Cancer Cell 然后,他们研究了 OGT 在小鼠体内促进肿瘤生长和转移的作用。他们发现巨噬细胞特异性缺乏 OGT 对体内肿瘤生长没有显著影响。然而,与对照组相比,巨噬细胞中 OGT 的缺失则可显著抑制肺转移,并可导致荷瘤小鼠的生存时间延长。此外,在切除原发肿瘤后,OGT 缺乏的荷瘤小鼠比对照组小鼠的生存率更高。这些结果表明,巨噬

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥5600
    上海研卉生物科技有限公司
    2025年07月15日询价
    询价
    武汉佰瑞得生物技术有限公司
    2025年07月16日询价
    ¥3000
    深圳市豪地华拓生物科技有限公司
    2025年11月13日询价
    ¥2650
    武汉维克赛思科技有限公司
    2025年07月12日询价
    询价
    艾美捷科技有限公司
    2025年07月11日询价
    小鼠体内用IL-4抗体,体内IL-4中和,体外IL-4中和,体内IL-4受体刺激
    ¥5600